Related Experiment Video
Updated: Feb 13, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Methamphetamine-Induced Cardiomyopathy (MACM) in a Middle-Aged Man; a Case Report
Zulfiqar Qutrio Baloch1, Muhammad Hussain2, Shabber Agha Abbas2
1Department of Internal Medicine, Brandon Regional Hospital, Brandon, Florida, USA.
Methamphetamine abuse can cause severe heart damage, leading to methamphetamine-associated cardiomyopathy (MACM). Early cardiac evaluation is crucial for intervention before irreversible heart failure develops.
Area of Science:
- Cardiology
- Toxicology
- Internal Medicine
Background:
- Methamphetamine abuse is a growing public health concern.
- Chronic methamphetamine use can lead to severe cardiac complications, including methamphetamine-associated cardiomyopathy (MACM).
- MACM can result in irreversible heart damage and decompensated heart failure, potentially requiring heart transplantation.
Observation:
- A 47-year-old male with a history of chronic amphetamine abuse presented with acute heart failure symptoms.
- Cardiac workup confirmed methamphetamine toxicity as the cause, ruling out other etiologies.
- The patient required intensive pharmacotherapy and was classified as NYHA Class III heart failure at discharge.
Findings:
- Methamphetamine-associated cardiomyopathy (MACM) is a severe complication of chronic methamphetamine abuse.
- MACM can lead to irreversible structural and functional cardiac changes, progressing to decompensated heart failure.
- Patients with MACM may present with symptoms of acute heart failure and require advanced interventions.
Implications:
- Increased methamphetamine abuse necessitates heightened clinical suspicion for MACM in emergency departments.
- Early cardiac evaluation in patients with a history of methamphetamine abuse can identify ventricular compromise.
- Prompt intervention may prevent irreversible cardiac damage and improve patient outcomes.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

